Jung Wha Kim-Shapiro, MD
- Clinical Assistant Professor, Pathology
Jung Wha Kim-Shapiro, MD
Research Interests
- Surgical Pathology
- Education
- MD, Wake Forest University School of Medicine, 2003
- Residency
- Pathology, Wake Forest Baptist Medical Center, 2007
- Fellowship
- Pathology, Wake Forest University School of Medicine, 2008
- Board Certifications
- American Board of Pathology, Pathology-Anatomic/Pathology-Clinical
- Positions
- Clinical Assistant Professor, Pathology
- Departments and Affiliations
- Pathology
Research
- Malignant Pericardial Mesothelioma Treated Using Volumetric Modulated Arc Therapy With a Simultaneous Integrated Boost. Steber C, Farris J, Hughes RT, Helis CA, Naal T, Kim-Shapiro JW, Jacobson T, Farris MK. Adv Radiat Oncol. ; 6(1):100562.
- Pearls & Oy-sters: IV and mechanical thrombolysis for ischemic stroke secondary to cardiac myxoma. Barghouthi T, Giugliano A, Kim-Shapiro JWL, Vu Q. Neurology. 2019 11; 93(22):975-977.
- Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements. Sanders AM, Stehle JR, Blanks MJ, Riedlinger G, Kim-Shapiro JW, Monjazeb AM, Adams JM, Willingham MC, Cui Z. BMC Cancer. 2010 Mar; 10:121.
- Impact of sex, MHC, and age of recipients on the therapeutic effect of transferred leukocytes from cancer-resistant SR/CR mice. Stehle JR, Blanks MJ, Riedlinger G, Kim-Shapiro JW, Sanders AM, Adams JM, Willingham MC, Cui Z. BMC Cancer. 2009 Sep; 9:328.
- Breast tumor cells isolated from in vitro resistance to trastuzumab remain sensitive to trastuzumab anti-tumor effects in vivo and to ADCC killing. Kute TE, Savage L, Stehle JR, Kim-Shapiro JW, Blanks MJ, Wood J, Vaughn JP. Cancer Immunol. Immunother. 2009 Nov; 58(11):1887-96.